半导体ETF（159813）业绩比较基准为国证半导体芯片指数收益率，管理人为鹏华基金管理有限公司， 基金经理为罗英宇，成立（2020-04-17）以来回报为86.00%，近一个月回报为3.62%。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 2月24日，半导体ETF（159813）开盘涨1.53%，报1.260元。半导体ETF（159813）重仓股方面，中芯国 际开盘涨0.94%，海光信息涨3.00%，寒武纪涨1.39%，北方华创涨1.17%，兆易创新涨2.85%，中微公司 涨1.26%，澜起科技涨3.27%，豪威集团涨1.02%，拓荆科技涨0.92%，长电科技涨1.67%。 来源：新浪基金∞工作室 ...

来源：新浪基金∞工作室 科创芯片ETF汇添富（588750）业绩比较基准为上证科创板芯片指数收益率，管理人为汇添富基金管理 股份有限公司，基金经理为孙浩，成立（2024-12-18）以来回报为78.38%，近一个月回报为5.60%。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 2月24日，科创芯片ETF汇添富（588750）开盘涨0.95%，报1.800元。科创芯片ETF汇添富（588750）重 仓股方面，中芯国际开盘涨0.94%，海光信息涨3.00%，寒武纪涨1.39%，澜起科技涨3.27%，中微公司 涨1.26%，拓荆科技涨0.92%，芯原股份涨3.45%，华虹公司涨0.16%，沪硅产业涨1.12%，东芯股份涨 0.91%。 ...

来源：新浪基金∞工作室 2月24日，芯片ETF天弘（159310）开盘涨1.12%，报2.342元。芯片ETF天弘（159310）重仓股方面，寒 武纪开盘涨1.39%，中芯国际涨0.94%，海光信息涨3.00%，北方华创涨1.17%，兆易创新涨2.85%，澜起 科技涨3.27%，中微公司涨1.26%，豪威集团涨1.02%，紫光国微涨1.02%，拓荆科技涨0.92%。 芯片ETF天弘（159310）业绩比较基准为中证芯片产业指数收益率，管理人为天弘基金管理有限公司， 基金经理为洪明华，成立（2024-04-18）以来回报为131.72%，近一个月回报为3.46%。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 ...

2）当下全球存储仍以典型周期资产估值定价，下一个阶段有望转向成长，估值将不再是5X、6X，而是10X、 15X、甚至20X。 持续强call存储设备，重视机器人催化【华西机械】 3）大陆存储扩产是景气度+国产替代共振，十五五两存+晋华预计扩产规划超过百万，显著强于海外，短期看两存 招标po临近。 持续强call存储设备，重视机器人催化【华西机械】 #1、1）春节假期海外指数普涨，欧洲、东亚等多国指数创新高；2）科技方向中存储板块表现强势，海力士、三 星等原厂股价再创新高，ASML、AMAT、LAM、泰瑞达等半导体设备龙头同样表现强势，股价逼近历史新高。 #1、1）春节假期海外指数普涨，欧洲、东亚等多国指数创新高；2）科技方向中存储板块表现强势，海力士、三 星等原厂股价再创新高，ASML、AMAT、LAM、泰瑞达等半导体设备龙头同样表现强势，股价逼近历史新高。 #2、1）2月20日海力士电话会议再次乐观指引全球存储景气度：一方面，AI带来的真实需求爆发，另一方面原厂 纪律性扩产以及洁净室限制导致供给失衡。 #2、1）2月20日海力士电话会议再次乐观指引全球存储景气度：一方面，AI带来的真实需求爆发，另一方面原厂 ...

来源：新浪基金∞工作室 芯片ETF（159995）业绩比较基准为国证半导体芯片指数收益率，管理人为华夏基金管理有限公司，基 金经理为赵宗庭，成立（2020-01-20）以来回报为93.54%，近一个月回报为3.60%。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 2月24日，芯片ETF（159995）开盘涨1.86%，报1.972元。芯片ETF（159995）重仓股方面，中芯国际开 盘涨0.94%，海光信息涨3.00%，寒武纪涨1.39%，北方华创涨1.17%，兆易创新涨2.85%，中微公司涨 1.26%，澜起科技涨3.27%，豪威集团涨1.02%，拓荆科技涨0.92%，长电科技涨1.67%。 ...

内容概况：在"后摩尔时代"，原子层沉积（ALD）技术凭借其独特的原子级精度和优异的三维保形性， 正从辅助工艺跃升为制造先进芯片三维结构的关键核心技术。2024年，中国ALD设备行业市场规模约 为45.22亿元，同比增长7.23%。一方面，集成电路制造正持续向更先进的节点突破，制造工艺步骤成倍 增加，直接拉动了对ALD设备的核心需求。另一方面，"超越摩尔"战略下的广阔应用正成为新的增长引 擎。高效太阳能电池（TOPCon）的产业化、OLED柔性显示的精密薄膜封装、锂电池固态电解质涂层 等新能源及新材料领域，正为ALD技术开辟远超传统半导体领域的巨大增量市场。 相关上市企业：微导纳米（688147）、拓荆科技（688072）、北方华创（002371）、中微公司 （688012） 相关企业：江苏南大光电材料股份有限公司、江苏雅克科技股份有限公司、华友钴业股份有限公司、赣 锋锂业股份有限公司、营口风光新材料股份有限公司、盈德气体集团有限公司、深圳市恒运昌真空技术 股份有限公司、中芯国际集成电路制造有限公司、隆基绿能科技股份有限公司、宁德时代新能源科技股 份有限公司、京东方科技集团股份有限公司、歌尔股份有限公司、迈瑞医 ...

Group 1 - The core point of the article is that the recent US Supreme Court ruling on the $175 billion tariff refund has significant implications for both China and the A-share market, despite the refund being an internal US matter [2][6][28] - The $175 billion in tariffs was primarily collected from imports, including a 10% tariff on Chinese goods, and is now being refunded to US importers [8][10] - The refund will indirectly benefit Chinese companies as US importers, who have been financially strained by tariffs, will use the refunded money to pay off debts to Chinese suppliers and resume orders [12][14][28] Group 2 - The immediate impact on the A-share market is expected to be positive, with a potential "opening red" for A-shares as market sentiment improves following the ruling [40][46] - The ruling is seen as a signal that the previous high tariffs on Chinese goods may not be a permanent state, which could lead to a more favorable environment for Chinese exports [20][48] - Structural opportunities in the A-share market are identified, focusing on five main lines: export-oriented sectors, domestic substitution, strategic resources, domestic consumption, and new energy [51][62][88] Group 3 - Export-oriented sectors, particularly those with high exposure to the US market, are expected to benefit directly from the tariff refunds, with companies like Midea Group and Haier expected to see improved performance [52][72][73] - Domestic substitution and self-sufficiency in sectors like semiconductors and military equipment are highlighted as long-term strategic focuses, with companies like SMIC and AVIC Shenyang Aircraft being key players [53][78][86] - Strategic resources such as rare earths and gold are also expected to see price support due to ongoing global supply chain disruptions, benefiting companies like Northern Rare Earth and Shandong Gold [56][87]

Core Viewpoint - The article discusses the current funding logic in the market, highlighting the significant movements of public funds in the technology sector, particularly in the semiconductor and biopharmaceutical industries, as they adjust their portfolios based on performance and valuation metrics [3][8]. Group 1: Public Fund Movements - Public funds have shown a notable shift in their holdings, particularly in the STAR Market, with the STAR 50 Index rising by 12.1% this year [3][4]. - The total market capitalization of STAR Market companies reached 10.4 trillion yuan, with the technology sector dominating, accounting for 62.1% of the total market cap [5][6]. - The semiconductor industry remains the core focus for fund allocation, with 12 companies in the sector having a market capitalization exceeding 10 billion yuan [9][11]. Group 2: Semiconductor Sector Insights - The market's pricing anchor for the semiconductor sector has shifted from "valuation expansion" to "performance realization," emphasizing the importance of actual earnings [13][14]. - Key drivers for future growth in the semiconductor sector include strong order backlogs, profit growth through acquisitions and expansions, and sustained price increases in advanced processes [13][14]. - Public funds have significantly increased their holdings in semiconductor materials, chip design, and equipment, with companies like ShenGong Co. seeing an 11% increase in fund holdings [15][21]. Group 3: Biopharmaceutical Sector Insights - The biopharmaceutical sector is a critical area for public funds, with major holdings in companies like BeiGene and United Imaging Healthcare, although the sector has faced a reduction in holdings for several key companies [24][26]. - The article notes that innovative drug companies are currently under pressure, with significant reductions in holdings observed in companies like BaiLi TianHeng and RongChang Biopharma [26][28]. - Despite the challenges, companies with strong earnings potential and innovative drug pipelines are still attracting interest from public funds, indicating a selective investment approach [35][40].

Group 1 - The core viewpoint of the article highlights the performance of the Chip Leader ETF (516640), which opened down by 0.67% at 1.179 yuan on February 13 [1] - The major holdings of the Chip Leader ETF include companies such as Cambricon, SMIC, and Haiguang Information, with varying performance; for instance, Cambricon fell by 1.12%, while Northern Huachuang rose by 1.00% [1] - The ETF's performance benchmark is the CSI Chip Industry Index return, managed by Fortune Fund Management Co., Ltd., with a return of 18.79% since its inception on August 19, 2021, and a recent one-month return of -0.29% [1]

Group 1 - The core point of the article highlights the performance of the chip ETF Guangfa (159801), which opened with a decline of 0.63% at 0.953 yuan [1] - Major holdings in the chip ETF include companies like Zhongxin International, which fell by 0.30%, and Haiguang Information, which decreased by 0.89% [1] - The ETF's performance benchmark is the National Securities Semiconductor Chip Index return rate, managed by Guangfa Fund Management Co., Ltd., with a return of 91.88% since its inception on January 20, 2020, and a recent one-month return of 0.16% [1] Group 2 - The article lists the performance of various stocks within the ETF, including Cambrian Technology down by 1.12%, and North Huachuang up by 1.00% [1] - Other notable stock performances include Zhaoyi Innovation unchanged at 0.00%, and Changdian Technology down by 1.35% [1] - The article emphasizes the importance of cautious investment due to market risks, although it does not provide specific investment advice [1]